Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download

  Colorectal Neoplasms

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 379 articles:
HTML format

Single Articles

    January 2020
  1. FRANCZAK C, Witz A, Geoffroy K, Demange J, et al
    Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.
    PLoS One. 2020;15:e0227294.
    PubMed     Abstract available

  2. JANA A, Das A, Krett NL, Guzman G, et al
    Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer.
    PLoS One. 2020;15:e0227916.
    PubMed     Abstract available

  3. CHAN JCY, Diakos CI, Engel A, Chan DLH, et al
    Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer.
    PLoS One. 2020;15:e0228466.
    PubMed     Abstract available

  4. HOFMANOVA J, Slavik J, Ovesna P, Tylichova Z, et al
    Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples.
    PLoS One. 2020;15:e0228010.
    PubMed     Abstract available

  5. IYADORAI T, Mariappan V, Vellasamy KM, Wanyiri JW, et al
    Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia.
    PLoS One. 2020;15:e0228217.
    PubMed     Abstract available

  6. CHARTIER LC, Hebart ML, Howarth GS, Whittaker AL, et al
    Affective state determination in a mouse model of colitis-associated colorectal cancer.
    PLoS One. 2020;15:e0228413.
    PubMed     Abstract available

  7. POWELL W, Frerichs L, Townsley R, Mayorga M, et al
    The potential impact of the Affordable Care Act and Medicaid expansion on reducing colorectal cancer screening disparities in African American males.
    PLoS One. 2020;15:e0226942.
    PubMed     Abstract available

  8. LEE JM, Park YM, Yun JS, Ahn YB, et al
    The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    PLoS One. 2020;15:e0226351.
    PubMed     Abstract available

  9. KOPP TI, Vogel U, Andersen V
    Associations between common polymorphisms in CYP2R1 and GC, Vitamin D intake and risk of colorectal cancer in a prospective case-cohort study in Danes.
    PLoS One. 2020;15:e0228635.
    PubMed     Abstract available

  10. YAMAJI T, Iwasaki M, Sawada N, Shimazu T, et al
    Fat mass and obesity-associated gene polymorphisms, pre-diagnostic plasma adipokine levels and the risk of colorectal cancer: The Japan Public Health Center-based Prospective Study.
    PLoS One. 2020;15:e0229005.
    PubMed     Abstract available

  11. OLSSON L, Hammarstrom ML, Israelsson A, Lindmark G, et al
    Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis.
    PLoS One. 2020;15:e0229007.
    PubMed     Abstract available

  12. LV Y, Duanmu J, Fu X, Li T, et al
    Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    PLoS One. 2020;15:e0228575.
    PubMed     Abstract available

  13. DARBA J, Marsa A
    Results after 10 years of colorectal cancer screenings in Spain: Hospital incidence and in-hospital mortality (2011-2016).
    PLoS One. 2020;15:e0228795.
    PubMed     Abstract available

  14. CLARKE SJ, Burge M, Feeney K, Gibbs P, et al
    The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].
    PLoS One. 2020;15:e0229900.
    PubMed     Abstract available

  15. GHARIB E, Nasrinasrabadi P, Zali MR
    Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
    PLoS One. 2020;15:e0229864.
    PubMed     Abstract available

  16. FARHANA L, Sarkar S, Nangia-Makker P, Yu Y, et al
    Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice.
    PLoS One. 2020;15:e0229823.
    PubMed     Abstract available

  17. TANAKA A, Zhou Y, Ogawa M, Shia J, et al
    STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability.
    PLoS One. 2020;15:e0229252.
    PubMed     Abstract available

  18. WHEELWRIGHT S, Permyakova NV, Calman L, Din A, et al
    Does quality of life return to pre-treatment levels five years after curative intent surgery for colorectal cancer? Evidence from the ColoREctal Wellbeing (CREW) study.
    PLoS One. 2020;15:e0231332.
    PubMed     Abstract available

  19. STEINER B, Ferrucci LM, Mirabello L, Lan Q, et al
    Association between coffee drinking and telomere length in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    PLoS One. 2020;15:e0226972.
    PubMed     Abstract available

  20. HIENSCH AE, Peeters PHM, Jansen M, van der Wall E, et al
    Socio-ecological correlates of physical activity in breast and colon cancer survivors 4 years after participation in a randomized controlled exercise trial (PACT study).
    PLoS One. 2020;15:e0231663.
    PubMed     Abstract available

  21. TRAMONTANO AC, Chen Y, Watson TR, Eckel A, et al
    Racial/ethnic disparities in colorectal cancer treatment utilization and phase-specific costs, 2000-2014.
    PLoS One. 2020;15:e0231599.
    PubMed     Abstract available

  22. DE'ANGELIS N, Baldini C, Brustia R, Pessaux P, et al
    Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0230914.
    PubMed     Abstract available

  23. FERRANDO L, Cirmena G, Garuti A, Scabini S, et al
    Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma.
    PLoS One. 2020;15:e0226595.
    PubMed     Abstract available

  24. WORTHINGTON J, Lew JB, Feletto E, Holden CA, et al
    Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
    PLoS One. 2020;15:e0227899.
    PubMed     Abstract available

  25. ALHAYYAN AM, McSorley ST, Kearns RJ, Horgan PG, et al
    The relationship between anaesthetic technique, clinicopathological characteristics and the magnitude of the postoperative systemic inflammatory response in patients undergoing elective surgery for colon cancer.
    PLoS One. 2020;15:e0228580.
    PubMed     Abstract available

  26. KANG JK, Heo S, Kim HP, Song SH, et al
    Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.
    PLoS One. 2020;15:e0232754.
    PubMed     Abstract available

  27. YAQOOB A, Li WM, Liu V, Wang C, et al
    Grifolin, neogrifolin and confluentin from the terricolous polypore Albatrellus flettii suppress KRAS expression in human colon cancer cells.
    PLoS One. 2020;15:e0231948.
    PubMed     Abstract available

  28. KUNOVSZKI P, Milassin A, Gimesi-Orszagh J, Takacs P, et al
    Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study.
    PLoS One. 2020;15:e0233238.
    PubMed     Abstract available

  29. PARISA A, Roya G, Mahdi R, Shabnam R, et al
    Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis.
    PLoS One. 2020;15:e0232930.
    PubMed     Abstract available

  30. CHEN C, Kuo YH, Lin CC, Chao CY, et al
    Decyl caffeic acid inhibits the proliferation of colorectal cancer cells in an autophagy-dependent manner in vitro and in vivo.
    PLoS One. 2020;15:e0232832.
    PubMed     Abstract available

  31. LIN TC, Chien WC, Hu JM, Tzeng NS, et al
    Risk of colorectal cancer in patients with alcoholism: A nationwide, population-based nested case-control study.
    PLoS One. 2020;15:e0232740.
    PubMed     Abstract available

  32. NOH GT, Han J, Cho MS, Hur H, et al
    The impact of early adjuvant chemotherapy in rectal cancer.
    PLoS One. 2020;15:e0228060.
    PubMed     Abstract available

  33. TAYLOR WS, Pearson J, Miller A, Schmeier S, et al
    MinION Sequencing of colorectal cancer tumour microbiomes-A comparison with amplicon-based and RNA-Sequencing.
    PLoS One. 2020;15:e0233170.
    PubMed     Abstract available

  34. DOUMA LN, Uiters E, Verweij MF, Timmermans DRM, et al
    Autonomous and informed decision-making: The case of colorectal cancer screening.
    PLoS One. 2020;15:e0233308.
    PubMed     Abstract available

  35. ZHAO P, Wu Z, Li C, Yang G, et al
    Postoperative analgesia using dezocine alleviates depressive symptoms after colorectal cancer surgery: A randomized, controlled, double-blind trial.
    PLoS One. 2020;15:e0233412.
    PubMed     Abstract available

  36. OGATA M, Kotaka M, Ogata T, Hatachi Y, et al
    Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.
    PLoS One. 2020;15:e0234314.
    PubMed     Abstract available

  37. ASADOLLAHI P, Ghanavati R, Rohani M, Razavi S, et al
    Correction: Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis.
    PLoS One. 2020;15:e0234777.
    PubMed     Abstract available

  38. HUANG CS, Chen CY, Huang LK, Wang WS, et al
    Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke.
    PLoS One. 2020;15:e0233687.
    PubMed     Abstract available

  39. HOLLANDSWORTH HM, Amirfakhri S, Filemoni F, Molnar J, et al
    Near-infrared photoimmunotherapy is effective treatment for colorectal cancer in orthotopic nude-mouse models.
    PLoS One. 2020;15:e0234643.
    PubMed     Abstract available

  40. NAKANISHI H, Sawada T, Kaizaki Y, Ota R, et al
    Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum.
    PLoS One. 2020;15:e0229262.
    PubMed     Abstract available

  41. HOLM M, Nummela P, Heiskanen A, Satomaa T, et al
    N-glycomic profiling of colorectal cancer according to tumor stage and location.
    PLoS One. 2020;15:e0234989.
    PubMed     Abstract available

  42. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    PubMed     Abstract available

  43. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    PubMed     Abstract available

  44. SANCHEZ-IBARRA HE, Jiang X, Gallegos-Gonzalez EY, Cavazos-Gonzalez AC, et al
    KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.
    PLoS One. 2020;15:e0235490.
    PubMed     Abstract available

  45. ULYTE A, Wei W, Dressel H, Gruebner O, et al
    Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
    PLoS One. 2020;15:e0231409.
    PubMed     Abstract available

  46. SHIM JW, Kim KR, Jung Y, Park J, et al
    Role of intraoperative oliguria in risk stratification for postoperative acute kidney injury in patients undergoing colorectal surgery with an enhanced recovery protocol: A propensity score matching analysis.
    PLoS One. 2020;15:e0231447.
    PubMed     Abstract available

  47. MAHAR AL, Kurdyak P, Hanna TP, Coburn NG, et al
    The effect of a severe psychiatric illness on colorectal cancer treatment and survival: A population-based retrospective cohort study.
    PLoS One. 2020;15:e0235409.
    PubMed     Abstract available

  48. WOLFE AE, Moskowitz JE, Franklin CL, Wiemken TL, et al
    Interactions of Segmented Filamentous Bacteria (Candidatus Savagella) and bacterial drivers in colitis-associated colorectal cancer development.
    PLoS One. 2020;15:e0236595.
    PubMed     Abstract available

  49. MUNRO MJ, Peng L, Wickremesekera SK, Tan ST, et al
    Colon adenocarcinoma-derived cells that express induced-pluripotent stem cell markers possess stem cell function.
    PLoS One. 2020;15:e0232934.
    PubMed     Abstract available

  50. ZHOU G, Xiao X, Tu M, Liu P, et al
    Computer aided detection for laterally spreading tumors and sessile serrated adenomas during colonoscopy.
    PLoS One. 2020;15:e0231880.
    PubMed     Abstract available

  51. SJOSTROM O, Dahlin AM, Silander G, Syk I, et al
    Travel time to care does not affect survival for patients with colorectal cancer in northern Sweden: A data linkage study from the Risk North database.
    PLoS One. 2020;15:e0236799.
    PubMed     Abstract available

  52. LU J, Jiang G, Wu Y, Antony S, et al
    NADPH oxidase 1 is highly expressed in human large and small bowel cancers.
    PLoS One. 2020;15:e0233208.
    PubMed     Abstract available

  53. GUO A, Drake BF, Khan YM, Langabeer Ii JR, et al
    Time-series cardiovascular risk factors and receipt of screening for breast, cervical, and colon cancer: The Guideline Advantage.
    PLoS One. 2020;15:e0236836.
    PubMed     Abstract available

  54. MATSUOKA H, Ando K, Swayze EJ, Unan EC, et al
    CTDSP1 inhibitor rabeprazole regulates DNA-PKcs dependent topoisomerase I degradation and irinotecan drug resistance in colorectal cancer.
    PLoS One. 2020;15:e0228002.
    PubMed     Abstract available

  55. NASRI NASRABADI P, Nayeri Z, Gharib E, Salmanipour R, et al
    Establishment of a CALU, AURKA, and MCM2 gene panel for discrimination of metastasis from primary colon and lung cancers.
    PLoS One. 2020;15:e0233717.
    PubMed     Abstract available

  56. GRAHAM LS, Montgomery B, Cheng HH, Yu EY, et al
    Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.
    PLoS One. 2020;15:e0233260.
    PubMed     Abstract available

  57. KLINGLER A, Regensburger D, Tenkerian C, Britzen-Laurent N, et al
    Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues.
    PLoS One. 2020;15:e0233422.
    PubMed     Abstract available

  58. AMLANI B, Radaelli F, Bhandari P
    A survey on colonoscopy shows poor understanding of its protective value and widespread misconceptions across Europe.
    PLoS One. 2020;15:e0233490.
    PubMed     Abstract available

  59. STROUS MTA, Daniels AM, Zimmermann FM, van Erning FN, et al
    Is pre-operative heart rate variability a prognostic indicator for overall survival and cancer recurrence in patients with primary colorectal cancer?
    PLoS One. 2020;15:e0237244.
    PubMed     Abstract available

  60. BADDER LM, Hollins AJ, Herpers B, Yan K, et al
    3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors.
    PLoS One. 2020;15:e0235319.
    PubMed     Abstract available

  61. WU F, Wang G, Wang J, Zhou C, et al
    Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer.
    PLoS One. 2020;15:e0234310.
    PubMed     Abstract available

  62. SANTOS-SANCHEZ V, Cordoba-Dona JA, Viciana F, Escolar-Pujolar A, et al
    Geographical variations in cancer mortality and social inequalities in southern Spain (Andalusia). 2002-2013.
    PLoS One. 2020;15:e0233397.
    PubMed     Abstract available

  63. FUJITA M, Fujisawa T, Hata A
    Additional outreach effort of providing an opportunity to obtain a kit for fecal immunochemical test during the general health check-up to improve colorectal cancer screening rate in Japan: A longitudinal study.
    PLoS One. 2020;15:e0238474.
    PubMed     Abstract available

  64. UEDA T, Morita K, Koyama F, Teramura Y, et al
    A detailed comparison between the endoscopic images using blue laser imaging and three-dimensional reconstructed pathological images of colonic lesions.
    PLoS One. 2020;15:e0235279.
    PubMed     Abstract available

  65. DALLA LIBERA LS, de Siqueira T, Santos IL, Porto Ramos JE, et al
    Detection of Human papillomavirus and the role of p16INK4a in colorectal carcinomas.
    PLoS One. 2020;15:e0235065.
    PubMed     Abstract available

  66. PASTORINO R, Basile M, Tognetto A, Di Marco M, et al
    Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy.
    PLoS One. 2020;15:e0235038.
    PubMed     Abstract available

  67. ROGERS CR, Matthews P, Xu L, Boucher K, et al
    Interventions for increasing colorectal cancer screening uptake among African-American men: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0238354.
    PubMed     Abstract available

  68. CONTICCHIO M, Papagni V, Notarnicola M, Delvecchio A, et al
    Laparoscopic vs. open mesorectal excision for rectal cancer: Are these approaches still comparable? A systematic review and meta-analysis.
    PLoS One. 2020;15:e0235887.
    PubMed     Abstract available

  69. SINGH AK, Talseth-Palmer B, McPhillips M, Lavik LAS, et al
    Targeted sequencing of genes associated with the mismatch repair pathway in patients with endometrial cancer.
    PLoS One. 2020;15:e0235613.
    PubMed     Abstract available

  70. TABORELLI M, Sozzi M, Del Zotto S, Toffolutti F, et al
    Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy.
    PLoS One. 2020;15:e0235142.
    PubMed     Abstract available

  71. MIYAMOTO Y, Schirripa M, Suenaga M, Cao S, et al
    A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer.
    PLoS One. 2020;15:e0239439.
    PubMed     Abstract available

  72. HILSDEN RJ, Maxwell CM, Forbes N, Bridges RJ, et al
    Development of a definition and rules for causal attribution of post-colonoscopy bleeding.
    PLoS One. 2020;15:e0235902.
    PubMed     Abstract available

  73. PELTONEN R, Gramkow MH, Dehlendorff C, Osterlund PJ, et al
    Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
    PLoS One. 2020;15:e0236569.
    PubMed     Abstract available

  74. KARABACHEV AD, Martini DJ, Hermel DJ, Solcz D, et al
    Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions.
    PLoS One. 2020;15:e0233673.
    PubMed     Abstract available

  75. KOI M, Okita Y, Takeda K, Koeppe ES, et al
    Co-morbid risk factors and NSAID use among white and black Americans that predicts overall survival from diagnosed colon cancer.
    PLoS One. 2020;15:e0239676.
    PubMed     Abstract available

  76. TAKASU C, Nishi M, Yoshikawa K, Tokunaga T, et al
    Impact of sidedness of colorectal cancer on tumor immunity.
    PLoS One. 2020;15:e0240408.
    PubMed     Abstract available

  77. CAI H, Zhang Y, Liu X, Jiang W, et al
    Association of age and cause-special mortality in patients with stage I/ II colon cancer: A population-based competing risk analysis.
    PLoS One. 2020;15:e0240715.
    PubMed     Abstract available

  78. KING LE, Zhang HH, Gould CM, Thomas DW, et al
    Genes regulating membrane-associated E-cadherin and proliferation in adenomatous polyposis coli mutant colon cancer cells: High content siRNA screen.
    PLoS One. 2020;15:e0240746.
    PubMed     Abstract available

  79. MASON SE, Scott AJ, Markar SR, Clarke JM, et al
    Insights from a global snapshot of the change in elective colorectal practice due to the COVID-19 pandemic.
    PLoS One. 2020;15:e0240397.
    PubMed     Abstract available

  80. MATTHES N, Diers J, Schlegel N, Hankir M, et al
    Validation of MTL30 as a quality indicator for colorectal surgery.
    PLoS One. 2020;15:e0238473.
    PubMed     Abstract available

  81. ZHANG T, Ahn K, Emerick B, Modarai SR, et al
    APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development.
    PLoS One. 2020;15:e0239601.
    PubMed     Abstract available

  82. HALE LP
    Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis.
    PLoS One. 2020;15:e0239295.
    PubMed     Abstract available

  83. NOH GT, Kwon J, Kim J, Park M, et al
    Verification of the role of exosomal microRNA in colorectal tumorigenesis using human colorectal cancer cell lines.
    PLoS One. 2020;15:e0242057.
    PubMed     Abstract available

  84. GABEL P, Larsen MB, Edwards A, Kirkegaard P, et al
    Effectiveness of a decision aid for colorectal cancer screening on components of informed choice according to educational attainment: A randomised controlled trial.
    PLoS One. 2020;15:e0241703.
    PubMed     Abstract available

  85. ASADOLLAHI P, Ghanavati R, Rohani M, Razavi S, et al
    Correction: Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis.
    PLoS One. 2020;15:e0242387.
    PubMed     Abstract available

  86. WANG Y, Xie G, Li M, Du J, et al
    COPB2 gene silencing inhibits colorectal cancer cell proliferation and induces apoptosis via the JNK/c-Jun signaling pathway.
    PLoS One. 2020;15:e0240106.
    PubMed     Abstract available

    January 2019
  87. NEILSEN BK, Frodyma DE, McCall JL, Fisher KW, et al
    ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells.
    PLoS One. 2019;14:e0209224.
    PubMed     Abstract available

  88. CHEN M, Xu R, Rai A, Suwakulsiri W, et al
    Distinct shed microvesicle and exosome microRNA signatures reveal diagnostic markers for colorectal cancer.
    PLoS One. 2019;14:e0210003.
    PubMed     Abstract available

  89. SARTOR ITS, Recamonde-Mendoza M, Ashton-Prolla P
    TULP3: A potential biomarker in colorectal cancer?
    PLoS One. 2019;14:e0210762.
    PubMed     Abstract available

  90. LEE YH, Kung PT, Wang YH, Kuo WY, et al
    Effect of length of time from diagnosis to treatment on colorectal cancer survival: A population-based study.
    PLoS One. 2019;14:e0210465.
    PubMed     Abstract available

  91. CHANG TC, Wei PL, Makondi PT, Chen WT, et al
    Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy.
    PLoS One. 2019;14:e0210274.
    PubMed     Abstract available

  92. RIOUX CR, Clapper ML, Cooper HS, Michaud J, et al
    Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models.
    PLoS One. 2019;14:e0210261.
    PubMed     Abstract available

  93. NERAD E, Delli Pizzi A, Lambregts DMJ, Maas M, et al
    The Apparent Diffusion Coefficient (ADC) is a useful biomarker in predicting metastatic colon cancer using the ADC-value of the primary tumor.
    PLoS One. 2019;14:e0211830.
    PubMed     Abstract available

  94. SHAHRIYARI L, Abdel-Rahman M, Cebulla C
    BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
    PLoS One. 2019;14:e0211507.
    PubMed     Abstract available

  95. KAPRIO T, Rasila T, Hagstrom J, Mustonen H, et al
    Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer.
    PLoS One. 2019;14:e0211564.
    PubMed     Abstract available

  96. KLOSE J, Trefz S, Wagner T, Steffen L, et al
    Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.
    PLoS One. 2019;14:e0211916.
    PubMed     Abstract available

  97. YANG B, Pan CS, Li Q, Yang Z, et al
    Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice.
    PLoS One. 2019;14:e0201504.
    PubMed     Abstract available

  98. DOUMA LN, Uiters E, Timmermans DRM
    Do people with a different goal-orientation or specific focus make different decisions about colorectal cancer-screening participation?
    PLoS One. 2019;14:e0213003.
    PubMed     Abstract available

  99. TSUTSUYAMA M, Nakanishi H, Yoshimura M, Oshiro T, et al
    Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform.
    PLoS One. 2019;14:e0212221.
    PubMed     Abstract available

  100. MAKONDI PT, Wei PL, Huang CY, Chang YJ, et al
    Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach.
    PLoS One. 2019;14:e0211968.
    PubMed     Abstract available

  101. ACKERMANN A, Schrecker C, Bon D, Friedrichs N, et al
    Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer.
    PLoS One. 2019;14:e0213411.
    PubMed     Abstract available

  102. YAMAGUCHI M, Okamura S, Yamaji T, Iwasaki M, et al
    Plasma cytokine levels and the presence of colorectal cancer.
    PLoS One. 2019;14:e0213602.
    PubMed     Abstract available

  103. STOFFEL ST, Yang J, Vlaev I, von Wagner C, et al
    Testing the decoy effect to increase interest in colorectal cancer screening.
    PLoS One. 2019;14:e0213668.
    PubMed     Abstract available

  104. KIM EJ, Woo HS, Cho JH, Sym SJ, et al
    Early experience with Watson for oncology in Korean patients with colorectal cancer.
    PLoS One. 2019;14:e0213640.
    PubMed     Abstract available

  105. FENG YY, Zeng DZ, Tong YN, Lu XX, et al
    Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
    PLoS One. 2019;14:e0215088.
    PubMed     Abstract available

  106. LI X, Zhong Q, Luo D, Du Q, et al
    The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer.
    PLoS One. 2019;14:e0214611.
    PubMed     Abstract available

  107. LIU Z, Duan ZJ, Chang JY, Zhang ZF, et al
    Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression.
    PLoS One. 2019;14:e0215388.

  108. NAKAYAMA Y, Iijima T, Wakaume R, Takahashi K, et al
    Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer.
    PLoS One. 2019;14:e0215513.
    PubMed     Abstract available

  109. ARRIBA M, Sanchez C, Vivas A, Nutu OA, et al
    Intermediate-onset colorectal cancer: A clinical and familial boundary between both early and late-onset colorectal cancer.
    PLoS One. 2019;14:e0216472.
    PubMed     Abstract available

  110. K B A, Madhavan A, T R R, Thomas S, et al
    Short chain fatty acids enriched fermentation metabolites of soluble dietary fibre from Musa paradisiaca drives HT29 colon cancer cells to apoptosis.
    PLoS One. 2019;14:e0216604.
    PubMed     Abstract available

  111. LU S, Catalano C, Huhn S, Pardini B, et al
    Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
    PLoS One. 2019;14:e0216666.
    PubMed     Abstract available

  112. LU S, Catalano C, Huhn S, Pardini B, et al
    Correction: Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
    PLoS One. 2019;14:e0218064.
    PubMed     Abstract available

  113. LIN XH, Jiang JK, Luo JC, Lin CC, et al
    The long term microbiota and metabolic status in patients with colorectal cancer after curative colon surgery.
    PLoS One. 2019;14:e0218436.
    PubMed     Abstract available

  114. CHAN JCY, Diakos CI, Engel A, Chan DLH, et al
    Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study.
    PLoS One. 2019;14:e0218207.
    PubMed     Abstract available

  115. VASHI PG, Gorsuch K, Wan L, Hill D, et al
    Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer.
    PLoS One. 2019;14:e0218761.
    PubMed     Abstract available

  116. CHEONG C, Oh SY, Kim YB, Suh KW, et al
    Differences in biological behaviors between young and elderly patients with colorectal cancer.
    PLoS One. 2019;14:e0218604.
    PubMed     Abstract available

  117. GILSON P, Franczak C, Dubouis L, Husson M, et al
    Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation.
    PLoS One. 2019;14:e0219204.
    PubMed     Abstract available

  118. KARLSSON E, Farahnak P, Franzen E, Nygren-Bonnier M, et al
    Feasibility of preoperative supervised home-based exercise in older adults undergoing colorectal cancer surgery - A randomized controlled design.
    PLoS One. 2019;14:e0219158.
    PubMed     Abstract available

  119. STOFFEL ST, Yang J, Vlaev I, von Wagner C, et al
    Correction: Testing the decoy effect to increase interest in colorectal cancer screening.
    PLoS One. 2019;14:e0219811.
    PubMed     Abstract available

  120. MIZUNO H, Yuasa N, Takeuchi E, Miyake H, et al
    Blood cell markers that can predict the long-term outcomes of patients with colorectal cancer.
    PLoS One. 2019;14:e0220579.
    PubMed     Abstract available

  121. TAIBI A, Albouys J, Jacques J, Perrin ML, et al
    Comparison of implantation sites for the development of peritoneal metastasis in a colorectal cancer mouse model using non-invasive bioluminescence imaging.
    PLoS One. 2019;14:e0220360.
    PubMed     Abstract available

  122. ZHAO Y, Yi C, Zhang Y, Fang F, et al
    Intensive follow-up strategies after radical surgery for nonmetastatic colorectal cancer: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2019;14:e0220533.
    PubMed     Abstract available

  123. LI W, Cho MY, Lee S, Jang M, et al
    CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition.
    PLoS One. 2019;14:e0220860.
    PubMed     Abstract available

  124. GLAZKO G, Zybailov B, Emmert-Streib F, Baranova A, et al
    Proteome-transcriptome alignment of molecular portraits achieved by self-contained gene set analysis: Consensus colon cancer subtypes case study.
    PLoS One. 2019;14:e0221444.
    PubMed     Abstract available

  125. NARTOWT BJ, Hart GR, Roffman DA, Llor X, et al
    Scoring colorectal cancer risk with an artificial neural network based on self-reportable personal health data.
    PLoS One. 2019;14:e0221421.
    PubMed     Abstract available

  126. CALLAHAN KE, Ponce CP, Cross CL, Sy FS, et al
    Low colorectal cancer survival in the Mountain West state of Nevada: A population-based analysis.
    PLoS One. 2019;14:e0221337.
    PubMed     Abstract available

  127. GMEREK L, Martyniak K, Horbacka K, Krokowicz P, et al
    MicroRNA regulation in colorectal cancer tissue and serum.
    PLoS One. 2019;14:e0222013.
    PubMed     Abstract available

  128. ALMUTAIRI M, Parine NR, Shaik JP, Aldhaian S, et al
    Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population.
    PLoS One. 2019;14:e0220931.
    PubMed     Abstract available

  129. NABER SK, Knudsen AB, Zauber AG, Rutter CM, et al
    Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries.
    PLoS One. 2019;14:e0220234.
    PubMed     Abstract available

  130. Retraction: APRIL Induces Tumorigenesis and Metastasis of Colorectal Cancer Cells via Activation of the PI3K/Akt Pathway.
    PLoS One. 2019;14:e0222525.

  131. CHEN N, Kong Y, Wu Y, Gao Q, et al
    CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer.
    PLoS One. 2019;14:e0222035.
    PubMed     Abstract available

  132. LU L, Zhuang T, Shao E, Liu Y, et al
    Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study.
    PLoS One. 2019;14:e0221964.
    PubMed     Abstract available

  133. LATHWAL A, Arora C, Raghava GPS
    Prediction of risk scores for colorectal cancer patients from the concentration of proteins involved in mitochondrial apoptotic pathway.
    PLoS One. 2019;14:e0217527.
    PubMed     Abstract available

  134. RAO S, Peri S, Hoffmann J, Cai KQ, et al
    RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance.
    PLoS One. 2019;14:e0222392.
    PubMed     Abstract available

  135. LICHTBLAU D, Stoean C
    Cancer diagnosis through a tandem of classifiers for digitized histopathological slides.
    PLoS One. 2019;14:e0209274.
    PubMed     Abstract available

  136. CHIU HC, Hsieh HM, Wan CL, Tsai HL, et al
    Cost-effectiveness of mini-laparotomy in patients with colorectal cancers: A propensity scoring matching approach.
    PLoS One. 2019;14:e0209970.
    PubMed     Abstract available

  137. PACHECO LS, Anderson CAM, Lacey JV Jr, Giovannucci EL, et al
    Sugar-sweetened beverages and colorectal cancer risk in the California Teachers Study.
    PLoS One. 2019;14:e0223638.
    PubMed     Abstract available

  138. LI F, Zhang C, Fu L
    PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway.
    PLoS One. 2019;14:e0218839.
    PubMed     Abstract available

  139. STRACCI F, Gili A, Naldini G, Gianfredi V, et al
    Geospatial analysis of the influence of family doctor on colorectal cancer screening adherence.
    PLoS One. 2019;14:e0222396.
    PubMed     Abstract available

  140. SOLIMAN C, Eastwood S, Truong VK, Ramsland PA, et al
    The membrane effects of melittin on gastric and colorectal cancer.
    PLoS One. 2019;14:e0224028.
    PubMed     Abstract available

  141. SINNER HF, Johnson J, Rychahou PG, Watt DS, et al
    Novel chemotherapeutic agent, FND-4b, activates AMPK and inhibits colorectal cancer cell proliferation.
    PLoS One. 2019;14:e0224253.
    PubMed     Abstract available

  142. KOJIMA K, Nakamura T, Ooizumi Y, Igarashi K, et al
    Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.
    PLoS One. 2019;14:e0211108.
    PubMed     Abstract available

  143. SHIIZAKI K, Kido K, Mizuta Y
    Insight into the relationship between aryl-hydrocarbon receptor and beta-catenin in human colon cancer cells.
    PLoS One. 2019;14:e0224613.
    PubMed     Abstract available

  144. HASAKOVA K, Reis R, Vician M, Zeman M, et al
    Expression of miR-34a-5p is up-regulated in human colorectal cancer and correlates with survival and clock gene PER2 expression.
    PLoS One. 2019;14:e0224396.
    PubMed     Abstract available

  145. WANG S, Shen HW, Chai H, Liang Y, et al
    Complex harmonic regularization with differential evolution in a memetic framework for biomarker selection.
    PLoS One. 2019;14:e0210786.
    PubMed     Abstract available

  146. FENG Q, Yu H, Sun S, Ma Z, et al
    The value of diffusion kurtosis imaging in assessing mismatch repair gene expression of rectal carcinoma: Preliminary findings.
    PLoS One. 2019;14:e0211461.
    PubMed     Abstract available

  147. MEDHIN LB, Achila OO, Abrham AT, Efrem B, et al
    Incidence of colorectal cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.
    PLoS One. 2019;14:e0224045.
    PubMed     Abstract available

  148. USHIGOME H, Fukunaga Y, Nagasaki T, Akiyoshi T, et al
    Difficulty of predicting lymph node metastasis on CT in patients with rectal neuroendocrine tumors.
    PLoS One. 2019;14:e0211675.
    PubMed     Abstract available

  149. SAITO K, Koido S, Odamaki T, Kajihara M, et al
    Metagenomic analyses of the gut microbiota associated with colorectal adenoma.
    PLoS One. 2019;14:e0212406.
    PubMed     Abstract available

  150. KO CW, Doria-Rose VP, Barrett MJ, Kamineni A, et al
    Screening colonoscopy and flexible sigmoidoscopy for reduction of colorectal cancer incidence: A case-control study.
    PLoS One. 2019;14:e0226027.
    PubMed     Abstract available

  151. EXARCHAKOU A, Donaldson LJ, Girardi F, Coleman MP, et al
    Colorectal cancer incidence among young adults in England: Trends by anatomical sub-site and deprivation.
    PLoS One. 2019;14:e0225547.
    PubMed     Abstract available

  152. HUANG Y, Li S, Yue H, Wang M, et al
    Impact of nominal photon energies on normal tissue sparing in knowledge-based radiotherapy treatment planning for rectal cancer patients.
    PLoS One. 2019;14:e0213271.
    PubMed     Abstract available

  153. HIRANO D, Urabe Y, Tanaka S, Nakamura K, et al
    Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes.
    PLoS One. 2019;14:e0211477.
    PubMed     Abstract available

  154. HE S, Carman CV, Lee JH, Lan B, et al
    The tumor suppressor p53 can promote collective cellular migration.
    PLoS One. 2019;14:e0202065.
    PubMed     Abstract available

  155. HSU JC, Lin JY, Lin PC, Lee YC, et al
    Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatment.
    PLoS One. 2019;14:e0225938.
    PubMed     Abstract available

  156. OHLEN J, Sawatzky R, Pettersson M, Sarenmalm EK, et al
    Preparedness for colorectal cancer surgery and recovery through a person-centred information and communication intervention - A quasi-experimental longitudinal design.
    PLoS One. 2019;14:e0225816.
    PubMed     Abstract available

  157. ALEGRIA-LERTXUNDI I, Aguirre C, Bujanda L, Fernandez FJ, et al
    Single nucleotide polymorphisms associated with susceptibility for development of colorectal cancer: Case-control study in a Basque population.
    PLoS One. 2019;14:e0225779.
    PubMed     Abstract available

  158. Epigenetic silencing of peroxisome proliferator-activated receptor gamma is a biomarker for colorectal cancer progression and adverse patients' outcome.
    PLoS One. 2019;14:e0227376.

  159. AWIDI M, Ababneh N, Shomaf M, Al Fararjeh F, et al
    KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan.
    PLoS One. 2019;14:e0226473.
    PubMed     Abstract available

  160. RENTOFT M, Svensson D, Sjodin A, Olason PI, et al
    A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis.
    PLoS One. 2019;14:e0213350.
    PubMed     Abstract available

  161. CHA YJ, Park EJ, Baik SH, Lee KY, et al
    Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis.
    PLoS One. 2019;14:e0214415.
    PubMed     Abstract available

  162. FRANCZAK C, Dubouis L, Gilson P, Husson M, et al
    Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.
    PLoS One. 2019;14:e0212801.
    PubMed     Abstract available

  163. MENDIVIL J, Appierto M, Aceituno S, Comas M, et al
    Economic evaluations of screening strategies for the early detection of colorectal cancer in the average-risk population: A systematic literature review.
    PLoS One. 2019;14:e0227251.
    PubMed     Abstract available

  164. LEE HJ, Park SJ, Cheon JH, Kim TI, et al
    The relationship between diverticulosis and colorectal neoplasia: A meta-analysis.
    PLoS One. 2019;14:e0216380.
    PubMed     Abstract available

  165. HASHEMIAN M, Murphy G, Etemadi A, Liao LM, et al
    Potato consumption and the risk of overall and cause specific mortality in the NIH-AARP study.
    PLoS One. 2019;14:e0216348.
    PubMed     Abstract available

  166. GASSER E, Braunwarth E, Riedmann M, Cardini B, et al
    Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
    PLoS One. 2019;14:e0217411.
    PubMed     Abstract available

  167. SAITO Y, Hinoi T, Adachi T, Miguchi M, et al
    Synbiotics suppress colitis-induced tumorigenesis in a colon-specific cancer mouse model.
    PLoS One. 2019;14:e0216393.
    PubMed     Abstract available

  168. ALAM MA, Shahjaman M, Rahman MF, Hossain F, et al
    Gene shaving using a sensitivity analysis of kernel based machine learning approach, with applications to cancer data.
    PLoS One. 2019;14:e0217027.
    PubMed     Abstract available

  169. JUROWICH C, Lichthardt S, Kastner C, Haubitz I, et al
    Laparoscopic versus open right hemicolectomy in colon carcinoma: A propensity score analysis of the DGAV StuDoQ|ColonCancer registry.
    PLoS One. 2019;14:e0218829.
    PubMed     Abstract available

  170. RABIN-COURT A, Rodrigues MR, Zhang XM, Perry RJ, et al
    Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.
    PLoS One. 2019;14:e0218126.
    PubMed     Abstract available

  171. YARCHOAN M, Mohan AA, Dennison L, Vithayathil T, et al
    MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity.
    PLoS One. 2019;14:e0224600.
    PubMed     Abstract available

  172. HIDALGO-TENORIO C, Gil-Anguita C, Lopez Ruz MA, Omar M, et al
    ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM.
    PLoS One. 2019;14:e0224183.
    PubMed     Abstract available

  173. KATSIDZIRA L, Vorster A, Gangaidzo IT, Makunike-Mutasa R, et al
    Investigation on the hereditary basis of colorectal cancers in an African population with frequent early onset cases.
    PLoS One. 2019;14:e0224023.
    PubMed     Abstract available

  174. GRUENDNER J, Schwachhofer T, Sippl P, Wolf N, et al
    KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services.
    PLoS One. 2019;14:e0223010.
    PubMed     Abstract available

  175. MUNRO MJ, Wickremesekera SK, Peng L, Marsh RW, et al
    Cancer stem cell subpopulations in primary colon adenocarcinoma.
    PLoS One. 2019;14:e0221963.
    PubMed     Abstract available

  176. CHEN R, Sugiyama A, Seno H, Sugimoto M, et al
    Identification of modules and functional analysis in CRC subtypes by integrated bioinformatics analysis.
    PLoS One. 2019;14:e0221772.
    PubMed     Abstract available

  177. SNOWSILL TM, Ryan NAJ, Crosbie EJ, Frayling IM, et al
    Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.
    PLoS One. 2019;14:e0221419.
    PubMed     Abstract available

  178. FLORESCU A, Branisteanu D, Bilha S, Scripcariu D, et al
    Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences.
    PLoS One. 2019;14:e0212471.
    PubMed     Abstract available

  179. WANG Q, Fu J, Chen X, Cai C, et al
    What factors are associated with the poor prognosis of anal adenocarcinoma compared with low-lying rectal adenocarcinoma based on a population analysis: A propensity score matching study.
    PLoS One. 2019;14:e0219937.
    PubMed     Abstract available

  180. JANSSEN TL, Steyerberg EW, Langenberg JCM, de Lepper CCHAVH, et al
    Multimodal prehabilitation to reduce the incidence of delirium and other adverse events in elderly patients undergoing elective major abdominal surgery: An uncontrolled before-and-after study.
    PLoS One. 2019;14:e0218152.
    PubMed     Abstract available

  181. MOFERS A, Perego P, Selvaraju K, Gatti L, et al
    Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15.
    PLoS One. 2019;14:e0223807.
    PubMed     Abstract available

  182. BERMUDEZ LUNA R, de Torres Olombrada MV
    mARC preoperative rectal cancer treatments vs. 3D conformal radiotherapy. A dose distribution comparative study.
    PLoS One. 2019;14:e0221262.
    PubMed     Abstract available

    January 2018
  183. LIN CY, Lin TH, Chen CC, Chen MC, et al
    Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study.
    PLoS One. 2018;13:e0190497.
    PubMed     Abstract available

  184. FAN F, Wang R, Boulbes DR, Zhang H, et al
    Macrophage conditioned medium promotes colorectal cancer stem cell phenotype via the hedgehog signaling pathway.
    PLoS One. 2018;13:e0190070.
    PubMed     Abstract available

  185. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    PubMed     Abstract available

  186. ZHANG Y, Liu H, Li L, Ai M, et al
    Correction: Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
    PLoS One. 2018;13:e0191587.
    PubMed     Abstract available

  187. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0191358.
    PubMed     Abstract available

  188. MUGHINI-GRAS L, Schaapveld M, Kramers J, Mooij S, et al
    Increased colon cancer risk after severe Salmonella infection.
    PLoS One. 2018;13:e0189721.
    PubMed     Abstract available

  189. MAKONDI PT, Lee CH, Huang CY, Chu CM, et al
    Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    PLoS One. 2018;13:e0189582.
    PubMed     Abstract available

  190. GOMES SE, Pereira DM, Roma-Rodrigues C, Fernandes AR, et al
    Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells.
    PLoS One. 2018;13:e0191607.
    PubMed     Abstract available

  191. SILVA DAS, Tremblay MS, Souza MFM, Mooney M, et al
    Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990-2015): Findings from the Global Burden of Disease Study.
    PLoS One. 2018;13:e0190943.
    PubMed     Abstract available

  192. LI F, Li Q, Wu X
    Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
    PLoS One. 2018;13:e0192494.
    PubMed     Abstract available

  193. CATALANO C, da Silva Filho MI, Frank C, Jiraskova K, et al
    Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.
    PLoS One. 2018;13:e0192385.
    PubMed     Abstract available

  194. HE Y, Penney ME, Negandhi AA, Parfrey PS, et al
    XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer.
    PLoS One. 2018;13:e0192316.
    PubMed     Abstract available

  195. SEO IS, Lee HG, Koo B, Koh CS, et al
    Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction.
    PLoS One. 2018;13:e0192629.
    PubMed     Abstract available

  196. SHETH H, Northwood E, Ulrich CM, Scherer D, et al
    Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
    PLoS One. 2018;13:e0192223.
    PubMed     Abstract available

  197. FRANZ J, Grunebaum J, Schafer M, Mulac D, et al
    Rhombic organization of microvilli domains found in a cell model of the human intestine.
    PLoS One. 2018;13:e0189970.
    PubMed     Abstract available

  198. MARCUELLO M, Mayol X, Felipe-Fumero E, Costa J, et al
    Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages: A preclinical model of surgery-associated inflammation and tumor recurrence.
    PLoS One. 2018;13:e0192958.
    PubMed     Abstract available

  199. CHOI JW, Kim DK, Kim JK, Lee EJ, et al
    A retrospective analysis on the relationship between intraoperative hypothermia and postoperative ileus after laparoscopic colorectal surgery.
    PLoS One. 2018;13:e0190711.
    PubMed     Abstract available

  200. GALLERY M, Zhang J, Bradley DP, Brauer P, et al
    A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
    PLoS One. 2018;13:e0191046.
    PubMed     Abstract available

  201. JUNG YS, Park CH, Kim NH, Park JH, et al
    Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results.
    PLoS One. 2018;13:e0191125.
    PubMed     Abstract available

  202. WANG H, Du K, Qu J, Chandarana H, et al
    Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer.
    PLoS One. 2018;13:e0190883.
    PubMed     Abstract available

  203. SCHIRRIPA M, Zhang W, Yang D, Cao S, et al
    NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
    PLoS One. 2018;13:e0193640.
    PubMed     Abstract available

  204. MARLICZ W, Poniewierska-Baran A, Rzeszotek S, Bartoszewski R, et al
    A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.
    PLoS One. 2018;13:e0189337.
    PubMed     Abstract available

  205. ARELAKI S, Arampatzioglou A, Kambas K, Sivridis E, et al
    Mast cells co-expressing CD68 and inorganic polyphosphate are linked with colorectal cancer.
    PLoS One. 2018;13:e0193089.
    PubMed     Abstract available

  206. HOF J, Joosten HJ, Havenga K, de Jong KP, et al
    Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    PLoS One. 2018;13:e0193385.
    PubMed     Abstract available

  207. FENG S, Zhou Q, Yang B, Li Q, et al
    The effect of S100A6 on nuclear translocation of CacyBP/SIP in colon cancer cells.
    PLoS One. 2018;13:e0192208.
    PubMed     Abstract available

  208. JIAO X, Liu W, Mahdessian H, Bryant P, et al
    Recurrent, low-frequency coding variants contributing to colorectal cancer in the Swedish population.
    PLoS One. 2018;13:e0193547.
    PubMed     Abstract available

  209. ORTIZ-ORTIZ KJ, Tortolero-Luna G, Rios-Motta R, Veintidos-Feliu A, et al
    Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.
    PLoS One. 2018;13:e0194415.
    PubMed     Abstract available

  210. HOLM M, Saraswat M, Joenvaara S, Ristimaki A, et al
    Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
    PLoS One. 2018;13:e0195354.
    PubMed     Abstract available

  211. LU J, Hu X, Meng Y, Zhao H, et al
    The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer.
    PLoS One. 2018;13:e0194804.
    PubMed     Abstract available

  212. SULZYC-BIELICKA V, Kolodziejczyk L, Jaczewska S, Bielicki D, et al
    Colorectal cancer and Cryptosporidium spp. infection.
    PLoS One. 2018;13:e0195834.
    PubMed     Abstract available

  213. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    PubMed     Abstract available

  214. LEE MK, Kim NK, Jeon JY
    Effect of the 6-week home-based exercise program on physical activity level and physical fitness in colorectal cancer survivors: A randomized controlled pilot study.
    PLoS One. 2018;13:e0196220.
    PubMed     Abstract available

  215. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
    A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    PLoS One. 2018;13:e0192744.
    PubMed     Abstract available

  216. MYTE R, Gylling B, Haggstrom J, Schneede J, et al
    One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
    PLoS One. 2018;13:e0196233.
    PubMed     Abstract available

  217. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0197008.
    PubMed     Abstract available

  218. KOJIMA K, Nakamura T, Ohbu M, Katoh H, et al
    Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
    PLoS One. 2018;13:e0194785.
    PubMed     Abstract available

  219. MOLPARIA B, Oliveira G, Wagner JL, Spencer EG, et al
    A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection.
    PLoS One. 2018;13:e0196826.
    PubMed     Abstract available

  220. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    Correction: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2018;13:e0197765.
    PubMed     Abstract available

  221. KUAN TC, Lin PC, Yang SH, Lin CC, et al
    Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients.
    PLoS One. 2018;13:e0197681.
    PubMed     Abstract available

  222. CHAT-UTHAI N, Vejvisithsakul P, Udommethaporn S, Meesiri P, et al
    Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.
    PLoS One. 2018;13:e0198795.
    PubMed     Abstract available

  223. JARZABEK MA, Proctor WR, Vogt J, Desai R, et al
    Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
    PLoS One. 2018;13:e0198099.
    PubMed     Abstract available

  224. AWAN R, Al-Maadeed S, Al-Saady R
    Using spectral imaging for the analysis of abnormalities for colorectal cancer: When is it helpful?
    PLoS One. 2018;13:e0197431.
    PubMed     Abstract available

  225. ALJARBOU F, Almousa N, Bazzi M, Aldaihan S, et al
    The expression of telomere-related proteins and DNA damage response and their association with telomere length in colorectal cancer in Saudi patients.
    PLoS One. 2018;13:e0197154.
    PubMed     Abstract available

  226. YU Y, Cheng D, Parfrey P, Liu G, et al
    Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer.
    PLoS One. 2018;13:e0198873.
    PubMed     Abstract available

  227. MESSARITAKIS I, Stogiannitsi M, Koulouridi A, Sfakianaki M, et al
    Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.
    PLoS One. 2018;13:e0197327.
    PubMed     Abstract available

  228. HUHN S, da Silva Filho MI, Sanmuganantham T, Pichulik T, et al
    Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer.
    PLoS One. 2018;13:e0199350.
    PubMed     Abstract available

  229. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    PubMed     Abstract available

  230. SAMRAJ AN, Bertrand KA, Luben R, Khedri Z, et al
    Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
    PLoS One. 2018;13:e0197464.
    PubMed     Abstract available

  231. QUINTANA JM, Anton-Ladislao A, Gonzalez N, Lazaro S, et al
    Predictors of one and two years' mortality in patients with colon cancer: A prospective cohort study.
    PLoS One. 2018;13:e0199894.
    PubMed     Abstract available

  232. GAVARUZZI T, Sarlo M, Giandomenico F, Rumiati R, et al
    Assessing emotions conveyed and elicited by patient narratives and their impact on intention to participate in colorectal cancer screening: A psychophysiological investigation.
    PLoS One. 2018;13:e0199882.
    PubMed     Abstract available

  233. PARK J, Kim JH, Park Y, Park SJ, et al
    Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence.
    PLoS One. 2018;13:e0193753.
    PubMed     Abstract available

  234. DAVIDSEN J, Larsen S, Coskun M, Gogenur I, et al
    The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
    PLoS One. 2018;13:e0200215.
    PubMed     Abstract available

  235. NODA M, Okayama H, Kofunato Y, Chida S, et al
    Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer.
    PLoS One. 2018;13:e0200315.
    PubMed     Abstract available

  236. INOUE M, Uchida Y, Edagawa M, Hirata M, et al
    The stress response gene ATF3 is a direct target of the Wnt/beta-catenin pathway and inhibits the invasion and migration of HCT116 human colorectal cancer cells.
    PLoS One. 2018;13:e0194160.
    PubMed     Abstract available

  237. FOSTER CC, Lee AY, Furtado LV, Hart J, et al
    Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.
    PLoS One. 2018;13:e0194234.
    PubMed     Abstract available

  238. PERRIER L, Rascle P, Morelle M, Toulmonde M, et al
    The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group.
    PLoS One. 2018;13:e0193330.
    PubMed     Abstract available

  239. WALI RK, Bianchi L, Kupfer S, De La Cruz M, et al
    Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial.
    PLoS One. 2018;13:e0193544.
    PubMed     Abstract available

  240. PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
    Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
    PLoS One. 2018;13:e0194790.
    PubMed     Abstract available

  241. MOJTABANEZHAD SHARIATPANAHI A, Yassi M, Nouraie M, Sahebkar A, et al
    The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
    PLoS One. 2018;13:e0200735.
    PubMed     Abstract available

  242. GUERCIO BJ, Zhang S, Niedzwiecki D, Li Y, et al
    Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).
    PLoS One. 2018;13:e0199244.
    PubMed     Abstract available

  243. ATREYA CE, Kubo A, Borno HT, Rosenthal B, et al
    Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers.
    PLoS One. 2018;13:e0199423.
    PubMed     Abstract available

  244. TAI YH, Chang WK, Wu HL, Chan MY, et al
    The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: A retrospective cohort study.
    PLoS One. 2018;13:e0200893.
    PubMed     Abstract available

  245. CHANG JY, Moon CM, Lee HJ, Yang HJ, et al
    Predictive factors for missed adenoma on repeat colonoscopy in patients with suboptimal bowel preparation on initial colonoscopy: A KASID multicenter study.
    PLoS One. 2018;13:e0195709.
    PubMed     Abstract available

  246. SAITA C, Yamaguchi T, Horiguchi SI, Yamada R, et al
    Tumor development in Japanese patients with Lynch syndrome.
    PLoS One. 2018;13:e0195572.
    PubMed     Abstract available

  247. EBELING M, Modig K, Ahlbom A, Rau R, et al
    The effects of increasing longevity and changing incidence on lifetime risk differentials: A decomposition approach.
    PLoS One. 2018;13:e0195307.
    PubMed     Abstract available

  248. TAKEDA Y, Akiyoshi T, Matsueda K, Fukuoka H, et al
    Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.
    PLoS One. 2018;13:e0195406.
    PubMed     Abstract available

  249. GHOSH R, Roy S, Franco S
    PARP1 depletion induces RIG-I-dependent signaling in human cancer cells.
    PLoS One. 2018;13:e0194611.
    PubMed     Abstract available

  250. JANSEN RJ, Alexander BH, Hayes RB, Miller AB, et al
    A mathematical model of case-ascertainment bias: Applied to case-control studies nested within a randomized screening trial.
    PLoS One. 2018;13:e0194608.
    PubMed     Abstract available

  251. WOLFF A, Bayerlova M, Gaedcke J, Kube D, et al
    A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells.
    PLoS One. 2018;13:e0197162.
    PubMed     Abstract available

  252. BOGACHEV MI, Volkov VY, Markelov OA, Trizna EY, et al
    Fast and simple tool for the quantification of biofilm-embedded cells sub-populations from fluorescent microscopic images.
    PLoS One. 2018;13:e0193267.
    PubMed     Abstract available

  253. KIM MJ, Hur BY, Lee ES, Park B, et al
    Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
    PLoS One. 2018;13:e0195815.
    PubMed     Abstract available

  254. BONNET E, Moutet ML, Baulard C, Bacq-Daian D, et al
    Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
    PLoS One. 2018;13:e0195471.
    PubMed     Abstract available

  255. SCHREMBS P, Martin B, Anthuber M, Schenkirsch G, et al
    The prognostic significance of lymph node size in node-positive colon cancer.
    PLoS One. 2018;13:e0201072.
    PubMed     Abstract available

  256. TAI YH, Chang WK, Wu HL, Chan MY, et al
    Correction: The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: A retrospective cohort study.
    PLoS One. 2018;13:e0202192.
    PubMed     Abstract available

  257. NEERINCX M, Poel D, Sie DLS, van Grieken NCT, et al
    Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.
    PLoS One. 2018;13:e0201809.
    PubMed     Abstract available

  258. STANILOVA S, Stanilov N, Julianov A, Manolova I, et al
    Transforming growth factor-beta1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
    PLoS One. 2018;13:e0201775.
    PubMed     Abstract available

  259. PRENTICE LM, Miller RR, Knaggs J, Mazloomian A, et al
    Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
    PLoS One. 2018;13:e0196434.
    PubMed     Abstract available

  260. PAL R, Wei N, Song N, Wu S, et al
    Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations.
    PLoS One. 2018;13:e0200836.
    PubMed     Abstract available

  261. DEN BAKKER CM, Anema JR, Zaman AGNM, de Vet HCW, et al
    Prognostic factors for return to work and work disability among colorectal cancer survivors; A systematic review.
    PLoS One. 2018;13:e0200720.
    PubMed     Abstract available

  262. LYNN H, Sun X, Ayshiev D, Siegler JH, et al
    Single nucleotide polymorphisms in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans.
    PLoS One. 2018;13:e0200916.
    PubMed     Abstract available

  263. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Opposite functions of GSN and OAS2 on colorectal cancer metastasis, mediating perineural and lymphovascular invasion, respectively.
    PLoS One. 2018;13:e0202856.
    PubMed     Abstract available

  264. MURCIA O, Juarez M, Rodriguez-Soler M, Hernandez-Illan E, et al
    Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
    PLoS One. 2018;13:e0203051.
    PubMed     Abstract available

  265. DHATCHANA MOORTHY N, Muthu Ramalingam B, Iqbal S, Mohanakrishnan AK, et al
    Novel isothiacalothrixin B analogues exhibit cytotoxic activity on human colon cancer cells in vitro by inducing irreversible DNA damage.
    PLoS One. 2018;13:e0202903.
    PubMed     Abstract available

  266. DECKER KM, Nugent Z, Lambert P, Biswanger N, et al
    Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
    PLoS One. 2018;13:e0203321.
    PubMed     Abstract available

  267. SEO MK, Cairns J
    Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer.
    PLoS One. 2018;13:e0204496.
    PubMed     Abstract available

  268. MARTIN-MORALES L, Rofes P, Diaz-Rubio E, Llovet P, et al
    Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition.
    PLoS One. 2018;13:e0203885.
    PubMed     Abstract available

  269. VAN DER WAALS LM, Borel Rinkes IHM, Kranenburg O
    ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    PLoS One. 2018;13:e0205536.
    PubMed     Abstract available

  270. KANG S, Kim BR, Kang MH, Kim DY, et al
    Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.
    PLoS One. 2018;13:e0205449.
    PubMed     Abstract available

  271. SU TC, Chen CY, Tsai WC, Hsu HT, et al
    Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
    PLoS One. 2018;13:e0204866.
    PubMed     Abstract available

  272. BROWN JC, Rhim AD, Manning SL, Brennan L, et al
    Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer.
    PLoS One. 2018;13:e0204875.
    PubMed     Abstract available

  273. Retraction: Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.
    PLoS One. 2018;13:e0206398.

  274. CHUN KA, Kocarnik JM, Hardikar SS, Robinson JR, et al
    Leptin gene variants and colorectal cancer risk: Sex-specific associations.
    PLoS One. 2018;13:e0206519.
    PubMed     Abstract available

  275. SHAH MS, DeSantis T, Yamal JM, Weir T, et al
    Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer.
    PLoS One. 2018;13:e0207002.
    PubMed     Abstract available

  276. MENG C, Yin X, Liu J, Tang K, et al
    TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis.
    PLoS One. 2018;13:e0207039.
    PubMed     Abstract available

  277. HERSTAD KMV, Moen AEF, Gaby JC, Moe L, et al
    Characterization of the fecal and mucosa-associated microbiota in dogs with colorectal epithelial tumors.
    PLoS One. 2018;13:e0198342.
    PubMed     Abstract available

  278. JODOIN R, Perreault JP
    G-quadruplexes formation in the 5'UTRs of mRNAs associated with colorectal cancer pathways.
    PLoS One. 2018;13:e0208363.
    PubMed     Abstract available

  279. GUO G, Chen X, He W, Wang H, et al
    Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data.
    PLoS One. 2018;13:e0208547.
    PubMed     Abstract available

  280. SHOJAEE S, Hajizadeh N, Najafimehr H, Busani L, et al
    Bayesian adjustment for trend of colorectal cancer incidence in misclassified registering across Iranian provinces.
    PLoS One. 2018;13:e0199273.
    PubMed     Abstract available

  281. AGYEMANG-YEBOAH F, Yorke J, Obirikorang C, Nsenbah Batu E, et al
    Colorectal cancer survival rates in Ghana: A retrospective hospital-based study.
    PLoS One. 2018;13:e0209307.
    PubMed     Abstract available

  282. DAMIN F, Galbiati S, Soriani N, Burgio V, et al
    Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients.
    PLoS One. 2018;13:e0207876.
    PubMed     Abstract available

  283. BAAS J, Krens L, Bohringer S, Mol L, et al
    Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab.
    PLoS One. 2018;13:e0208080.
    PubMed     Abstract available

  284. HAGMAN H, Bendahl PO, Lidfeldt J, Belting M, et al
    Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer.
    PLoS One. 2018;13:e0209838.
    PubMed     Abstract available

  285. LAW E, Levesque JV, Lambert S, Girgis A, et al
    The "sphere of care": A qualitative study of colorectal cancer patient and caregiver experiences of support within the cancer treatment setting.
    PLoS One. 2018;13:e0209436.
    PubMed     Abstract available

  286. WANG X, Zheng B, Lu X, Bai R, et al
    Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data.
    PLoS One. 2018;13:e0200142.
    PubMed     Abstract available

  287. BAUMER N, Rehkamper J, Appel N, Terheyden L, et al
    Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth.
    PLoS One. 2018;13:e0200163.
    PubMed     Abstract available

  288. TATEBAYASHI D, Himori K, Yamada R, Ashida Y, et al
    High-intensity eccentric training ameliorates muscle wasting in colon 26 tumor-bearing mice.
    PLoS One. 2018;13:e0199050.
    PubMed     Abstract available

  289. SOMMER CA, Capilla A, Molina-Estevez FJ, Gianotti-Sommer A, et al
    Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells.
    PLoS One. 2018;13:e0200657.
    PubMed     Abstract available

  290. AUGUSTUS GJ, Roe DJ, Jacobs ET, Lance P, et al
    Is increased colorectal screening effective in preventing distant disease?
    PLoS One. 2018;13:e0200462.
    PubMed     Abstract available

  291. PIASECKI P, Narloch J, Brzozowski K, Ziecina P, et al
    The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.
    PLoS One. 2018;13:e0200488.
    PubMed     Abstract available

  292. RODRIGUEZ-ALONSO L, Rodriguez-Moranta F, Arajol C, Gilabert P, et al
    Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients.
    PLoS One. 2018;13:e0203359.
    PubMed     Abstract available

  293. REDFORD L, Alhilal G, Needham S, O'Brien O, et al
    A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumours.
    PLoS One. 2018;13:e0203052.
    PubMed     Abstract available

  294. ESTEVA M, Ruiz-Diaz M, Sanchez MA, Pertega S, et al
    Emergency presentation of colorectal patients in Spain.
    PLoS One. 2018;13:e0203556.
    PubMed     Abstract available

  295. MILONE M, Manigrasso M, Burati M, Velotti N, et al
    Surgical resection for rectal cancer. Is laparoscopic surgery as successful as open approach? A systematic review with meta-analysis.
    PLoS One. 2018;13:e0204887.
    PubMed     Abstract available

  296. MAJUMDER S, Shah R, Elias J, Mistry Y, et al
    A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.
    PLoS One. 2018;13:e0203845.
    PubMed     Abstract available

  297. INABA S, Hinohara A, Tachibana M, Tsujikawa K, et al
    Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential.
    PLoS One. 2018;13:e0205467.
    PubMed     Abstract available

  298. PEACOCK SD, Massey TE, Vanner SJ, King WD, et al
    Telomere length in the colon is related to colorectal adenoma prevalence.
    PLoS One. 2018;13:e0205697.
    PubMed     Abstract available

  299. CAMPOS NA, da Cunha MSB, Arruda SF
    Tucum-do-cerrado (Bactris setosa Mart.) modulates oxidative stress, inflammation, and apoptosis-related proteins in rats treated with azoxymethane.
    PLoS One. 2018;13:e0206670.
    PubMed     Abstract available

  300. KIRAGA L, Cheda L, Taciak B, Rozanska K, et al
    Changes in hypoxia level of CT26 tumors during various stages of development and comparing different methods of hypoxia determination.
    PLoS One. 2018;13:e0206706.
    PubMed     Abstract available

  301. SHRIVASTAV M, Gounaris E, Khan MW, Ko J, et al
    Validation of near infrared fluorescence (NIRF) probes in vivo with dual laser NIRF endoscope.
    PLoS One. 2018;13:e0206568.
    PubMed     Abstract available

  302. CAMPAYO M, Navarro A, Benitez JC, Santasusagna S, et al
    miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.
    PLoS One. 2018;13:e0206542.
    PubMed     Abstract available

  303. CHEN YY, Fang WH, Wang CC, Kao TW, et al
    Detrimental association between betel nut chewing and colorectal polyps in adult populations.
    PLoS One. 2018;13:e0206383.
    PubMed     Abstract available

  304. KANG YJ, Smith M, Canfell K
    Anal cancer in high-income countries: Increasing burden of disease.
    PLoS One. 2018;13:e0205105.
    PubMed     Abstract available

  305. GRACE D, Gaspar M, Paquette R, Rosenes R, et al
    HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study.
    PLoS One. 2018;13:e0207953.
    PubMed     Abstract available

  306. HUANG MH, Blackwood J, Godoshian M, Pfalzer L, et al
    Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    PLoS One. 2018;13:e0208573.
    PubMed     Abstract available

    January 2017
  307. SIEBENKAS C, Chiappinelli KB, Guzzetta AA, Sharma A, et al
    Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.
    PLoS One. 2017;12:e0179501.
    PubMed     Abstract available

  308. BOOT A, Oosting J, van Eendenburg JDH, Kuppen PJK, et al
    Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
    PLoS One. 2017;12:e0184900.
    PubMed     Abstract available

  309. ZHAN Z, Verberne CJ, van den Heuvel ER, Grossmann I, et al
    Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for colorectal cancer.
    PLoS One. 2017;12:e0184740.
    PubMed     Abstract available

  310. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    PubMed     Abstract available

  311. WANG B, Yang J, Li S, Lv M, et al
    Tumor location as a novel high risk parameter for stage II colorectal cancers.
    PLoS One. 2017;12:e0179910.
    PubMed     Abstract available

  312. KURACHA MR, Thomas P, Loggie BW, Govindarajan V, et al
    Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies.
    PLoS One. 2017;12:e0179510.
    PubMed     Abstract available

  313. LI Z, Li SA, Sun Y, Liu Y, et al
    TNF-alpha -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China.
    PLoS One. 2017;12:e0178218.
    PubMed     Abstract available

  314. IWATA T, Uchino T, Koyama A, Johmura Y, et al
    The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
    PLoS One. 2017;12:e0178221.
    PubMed     Abstract available

  315. PENG YC, Lin CL, Sung FC
    The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
    PLoS One. 2017;12:e0177745.
    PubMed     Abstract available

  316. LAMBERTI MJ, Pansa MF, Vera RE, Fernandez-Zapico ME, et al
    Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy.
    PLoS One. 2017;12:e0177801.
    PubMed     Abstract available

  317. DE WIT M, Carvalho B, Delis-van Diemen PM, van Alphen C, et al
    Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    PLoS One. 2017;12:e0174768.
    PubMed     Abstract available

  318. COEBERGH VAN DEN BRAAK RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, et al
    High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    PLoS One. 2017;12:e0185607.
    PubMed     Abstract available

  319. NIIKURA R, Hirata Y, Suzuki N, Yamada A, et al
    Colonoscopy reduces colorectal cancer mortality: A multicenter, long-term, colonoscopy-based cohort study.
    PLoS One. 2017;12:e0185294.
    PubMed     Abstract available

  320. SLIK K, Kurki S, Korpela T, Carpen O, et al
    Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer.
    PLoS One. 2017;12:e0185436.
    PubMed     Abstract available

  321. XU R, Lin L, Li Y, Li Y, et al
    ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0185254.
    PubMed     Abstract available

  322. HILSDEN RJ, Bridges R, Dube C, Heitman SJ, et al
    Scheduling rules for patients with diabetes mellitus that facilitate split-dosing improve the quality of bowel preparation for colonoscopy.
    PLoS One. 2017;12:e0182225.
    PubMed     Abstract available

  323. HOCHMAN G, Halevi-Tobias K, Kogan Y, Agur Z, et al
    Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model.
    PLoS One. 2017;12:e0179888.
    PubMed     Abstract available

  324. HENNENBERG EM, Eyking A, Reis H, Cario E, et al
    MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.
    PLoS One. 2017;12:e0180834.
    PubMed     Abstract available

  325. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Abstract available

  326. BLAGOEV KB, Wilkerson J, Burotto M, Kim C, et al
    Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status.
    PLoS One. 2017;12:e0175484.
    PubMed     Abstract available

  327. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2017;12:e0185778.
    PubMed     Abstract available

  328. LIN GL, Ting HJ, Tseng TC, Juang V, et al
    Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    PLoS One. 2017;12:e0185625.
    PubMed     Abstract available

  329. MORUZZI S, Guarini P, Udali S, Ruzzenente A, et al
    One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.
    PLoS One. 2017;12:e0185792.
    PubMed     Abstract available

  330. TSENG JC, Narayanan N, Ho G, Groves K, et al
    Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    PLoS One. 2017;12:e0182689.
    PubMed     Abstract available

  331. LI P, Xiao Z, Braciak TA, Ou Q, et al
    Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.
    PLoS One. 2017;12:e0181615.
    PubMed     Abstract available

  332. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    PubMed     Abstract available

  333. MURPHY C, Rettedal E, Lehouritis P, Devoy C, et al
    Intratumoural production of TNFalpha by bacteria mediates cancer therapy.
    PLoS One. 2017;12:e0180034.
    PubMed     Abstract available

  334. RIVA A, BOrgesen M, Guldmann-Christensen M, Hauge Kyneb M, et al
    SensiScreen(R)KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
    PLoS One. 2017;12:e0178027.
    PubMed     Abstract available

  335. SINN DH, Min YW, Son HJ, Rhee PL, et al
    Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma.
    PLoS One. 2017;12:e0179480.
    PubMed     Abstract available

  336. JUNG SY, Rohan T, Strickler H, Bea J, et al
    Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
    PLoS One. 2017;12:e0186296.
    PubMed     Abstract available

  337. LI Y, Li J, Liu H, Liu Y, et al
    Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer.
    PLoS One. 2017;12:e0186530.
    PubMed     Abstract available

  338. CHEE CG, Kim YH, Lee KH, Lee YJ, et al
    CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
    PLoS One. 2017;12:e0182883.
    PubMed     Abstract available

  339. DIAO R, Mu X, Wang T, Li S, et al
    Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma.
    PLoS One. 2017;12:e0182908.
    PubMed     Abstract available

  340. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    PubMed     Abstract available

  341. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    PubMed     Abstract available

  342. DARLING NJ, Balmanno K, Cook SJ
    ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death.
    PLoS One. 2017;12:e0184907.
    PubMed     Abstract available

  343. KAWAKUBO M, Demehri S, Manstein D
    Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.
    PLoS One. 2017;12:e0184852.
    PubMed     Abstract available

  344. HUANG JY, Wang R, Gao YT, Yuan JM, et al
    ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
    PLoS One. 2017;12:e0184295.
    PubMed     Abstract available

  345. KUMARASAMY V, Kuppusamy UR, Jayalakshmi P, Samudi C, et al
    Exacerbation of colon carcinogenesis by Blastocystis sp.
    PLoS One. 2017;12:e0183097.
    PubMed     Abstract available

  346. OLSSON PO, Kalamajski S, Maccarana M, Oldberg A, et al
    Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma.
    PLoS One. 2017;12:e0182973.
    PubMed     Abstract available

  347. YOKOYAMA S, Takeuchi A, Yamaguchi S, Mitani Y, et al
    Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA.
    PLoS One. 2017;12:e0183337.
    PubMed     Abstract available

  348. GORFINE M, Berndt SI, Chang-Claude J, Hoffmeister M, et al
    Heritability Estimation using a Regularized Regression Approach (HERRA): Applicable to continuous, dichotomous or age-at-onset outcome.
    PLoS One. 2017;12:e0181269.
    PubMed     Abstract available

  349. PRABHU VV, Lulla AR, Madhukar NS, Ralff MD, et al
    Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    PLoS One. 2017;12:e0180541.
    PubMed     Abstract available

  350. XU Q, Tong JL, Zhang CP, Xiao Q, et al
    miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4.
    PLoS One. 2017;12:e0186718.
    PubMed     Abstract available

  351. LEI S, Ding Y, Fu Y, Wu S, et al
    The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.
    PLoS One. 2017;12:e0184501.
    PubMed     Abstract available

  352. PRALL F, Maletzki C, Huhns M, Krohn M, et al
    Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment.
    PLoS One. 2017;12:e0186271.
    PubMed     Abstract available

  353. JUAREZ M, Egoavil C, Rodriguez-Soler M, Hernandez-Illan E, et al
    KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.
    PLoS One. 2017;12:e0184937.
    PubMed     Abstract available

  354. MANIKIS GC, Marias K, Lambregts DMJ, Nikiforaki K, et al
    Diffusion weighted imaging in patients with rectal cancer: Comparison between Gaussian and non-Gaussian models.
    PLoS One. 2017;12:e0184197.
    PubMed     Abstract available

  355. HONG SN, Son HJ, Choi SK, Chang DK, et al
    A prediction model for advanced colorectal neoplasia in an asymptomatic screening population.
    PLoS One. 2017;12:e0181040.
    PubMed     Abstract available

  356. SCOTT AJ, Song EK, Bagby S, Purkey A, et al
    Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.
    PLoS One. 2017;12:e0187173.
    PubMed     Abstract available

  357. ROSWALL N, Bidstrup PE, Raaschou-Nielsen O, Solvang Jensen S, et al
    Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study.
    PLoS One. 2017;12:e0187161.
    PubMed     Abstract available

  358. MYUNG DS, Kweon SS, Lee J, Shin IS, et al
    Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID).
    PLoS One. 2017;12:e0184205.
    PubMed     Abstract available

  359. BRAND EC, Crook JE, Thomas CS, Siersema PD, et al
    Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates.
    PLoS One. 2017;12:e0185560.
    PubMed     Abstract available

  360. YU Z, Chen Z, Wu J, Li Z, et al
    Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0188139.
    PubMed     Abstract available

  361. PARK H, Cho S, Woo H, Park SK, et al
    Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort.
    PLoS One. 2017;12:e0188465.
    PubMed     Abstract available

  362. BIEN SA, Auer PL, Harrison TA, Qu C, et al
    Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data.
    PLoS One. 2017;12:e0186518.
    PubMed     Abstract available

  363. HUO T, Canepa R, Sura A, Modave F, et al
    Colorectal cancer stages transcriptome analysis.
    PLoS One. 2017;12:e0188697.
    PubMed     Abstract available

  364. ROVELLI C, Poli A, Galli L, Cernuschi M, et al
    Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males.
    PLoS One. 2017;12:e0186367.
    PubMed     Abstract available

  365. ZHANG Z, Zheng F, Yu Z, Hao J, et al
    XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers.
    PLoS One. 2017;12:e0186900.
    PubMed     Abstract available

  366. HWANG IC, Chang J, Park SM
    Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
    PLoS One. 2017;12:e0189114.
    PubMed     Abstract available

  367. BERRY RS, Xiong MJ, Greenbaum A, Mortaji P, et al
    High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer.
    PLoS One. 2017;12:e0188799.
    PubMed     Abstract available

  368. LORCA V, Rueda D, Martin-Morales L, Poves C, et al
    Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome.
    PLoS One. 2017;12:e0187312.
    PubMed     Abstract available

  369. HOEDJES M, de Kruif A, Mols F, Bours M, et al
    An exploration of needs and preferences for dietary support in colorectal cancer survivors: A mixed-methods study.
    PLoS One. 2017;12:e0189178.
    PubMed     Abstract available

  370. SERRANO-VILLAR S, Hernandez-Novoa B, de Benito A, Del Romero J, et al
    Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM.
    PLoS One. 2017;12:e0188851.
    PubMed     Abstract available

  371. GRAF JF, Zavodszky MI
    Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures.
    PLoS One. 2017;12:e0188878.
    PubMed     Abstract available

  372. MA L, Wang L, Shan Y, Nafees M, et al
    Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma.
    PLoS One. 2017;12:e0188665.
    PubMed     Abstract available

  373. ANANTHARAJU PG, Reddy DB, Padukudru MA, Chitturi CMK, et al
    Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC).
    PLoS One. 2017;12:e0186208.
    PubMed     Abstract available

  374. VIRGONE-CARLOTTA A, Lemasson M, Mertani HC, Diaz JJ, et al
    In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.
    PLoS One. 2017;12:e0188100.
    PubMed     Abstract available

  375. KO Y, Kim J, Park JK, Kim H, et al
    Limited detection of small (</= 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection.
    PLoS One. 2017;12:e0189797.
    PubMed     Abstract available

  376. KOENIG A, Krug S, Mueller D, Barth PJ, et al
    Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.
    PLoS One. 2017;12:e0188876.
    PubMed     Abstract available

  377. OSMAN M, Benamrouz S, Guyot K, Baydoun M, et al
    High association of Cryptosporidium spp. infection with colon adenocarcinoma in Lebanese patients.
    PLoS One. 2017;12:e0189422.
    PubMed     Abstract available

  378. GONG J, Bai T, Zhang L, Qian W, et al
    Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro.
    PLoS One. 2017;12:e0189257.
    PubMed     Abstract available

  379. O'NEIL BH, Wallmark JM, Lorente D, Elez E, et al
    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
    PLoS One. 2017;12:e0189848.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.